Browse > Article

Inhibition of osteoclast formation by putative human cementoblasts  

Kim, Mi-Ri (Department of Dentistry, Asan Medical Center, University of Ulsan)
Yang, Won-Kyung (Department of Dentistry, Asan Medical Center, University of Ulsan)
Grzesik, Wojciech (Department of Anatomy and Cell Biology, School of Dental Medicine, University of Pennsylvania)
Ko, Hyun-Jung (Department of Dentistry, Asan Medical Center, University of Ulsan)
Publication Information
International Journal of Oral Biology / v.33, no.3, 2008 , pp. 113-116 More about this Journal
Abstract
Cementum is the mineralized tissue of the tooth. It is similar to bone in several aspects but it differs from bone. Human bone marrow stromal cells (BMSC) and human cementum derived cells (HCDC) (10,000 $cells/cm^2$) were plated in 6 well plates as feeder cells. The next day, mouse bone marrow cells (1.5 million $cells/cm^2$) were added. One group of these plates were incubated in serum-free conditioned medium (SFCM) generated from BMSC or HCDC supplemented with 2% FBS, parathyroid hormone (PTH), 1, 25 dihydroxyvitamin $D_3$ (Vit. $D_3$) and dexamethasone, or plain medium with the same supplements. Another group of plates were cocultured with BMSC or HCDC in plain medium supplemented with 2% FBS, PTH, Vit. $D_3$ and dexamethasone. Plates grown without SFCM or coculture were used as controls. After 10 days, the cells were stained for tartrate-resistant acid phosphatase (TRAP). BMSC were found to support osteoclast formation under normal conditions. This was inhibited however by both SFCM generated from HCDC and also by coculture with HCDC. In addition, HCDC themselves did not support osteoclast formation under any conditions. Our results thus indicate that HCDC do not support osteoclast formation in vitro and that soluble factor (s) from HCDC may inhibit this process. In addition, we show that this inhibition also involves an active mechanism that is independent of osteoprotegerin, a feature that may distinguish cementoblasts from other cells present in periodontium.
Keywords
BMSC (bone marrow stromal cells); HCDC (human cementum derived cells); osteoclast; TRAP(Tartrate resistant acid phosphatase) assay;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Bianco P, Kuznetsov SA, Riminucci M, Fisher LW, Spiegel AM, Robey P. A miniature of human fibrous dysplasia of bone reproduced in immunodeficient mice by transplantation of mosaics of normal and Gs alpha-mutated marrow stromal fibroblasts. J Clin Invest. 1998;101:1737- 1744   DOI   ScienceOn
2 Krebsbach PH, Kuznetsov SA, Satomura K, Emmons RVB, Rowe DW, Robey PG. Bone formation in vivo comparison of osteogenesis by transplanted mouse and human marrow stromal fibroblasts. Transplantation. 1997;63:1059-1069   DOI   ScienceOn
3 Roux S and Orcel P. Bone loss factors that regulate osteoclast differentiation. : an update. Arthritis Res. 2000;2;451-456   DOI   ScienceOn
4 Katz RW, Hollinger JO, Reddi AH. The functional equivalence of demineralized bone and tooth matrices in ectopic bone induction. J Biomed Mater Res. 1993;27(2):239-45   DOI
5 Jones SJ, Arora M, Boyde A. The rate of osteoclastic destruction of calcified tissues is inversely proportional to mineral density. Calcif Tissue Int. 1995;56(6):554-8   DOI
6 Cha Ji-Hun, Ryoo HM, Woo KM, Kim GS, Baek JH. Dlx3 Plays a Role as a Positive Regulator of Osteoclast Differentiation. Int J Oral Biol. 2007;32(3):85-91   과학기술학회마을
7 Wise GE, Yao S, Zhang Q, Ren Y. Inhibition of osteoclastogenesis by the secretion of osteoprotegerin in vitro by rat dental follicle cells and its implications for tooth eruption. Arch Oral Biol. 2002;47(3):247-54   DOI   ScienceOn
8 Bell N. RANK ligand and modulation of skeletal remodeling. J Clin Invest. 2003;111:1120-1122   DOI
9 Hasegawa T, Yoshimura Y, Kikuiri T, Yawaka Y, Takeyama S, Matsumoto A, Oguchi H, Shirakawa T. Expression of receptor activator of NF-kappa B ligand and osteoprotegerin in culture of human periodontal ligament cells. J Periodontal Res. 2002;37(6):405-11   DOI   ScienceOn
10 Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ. Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev. 1999;20(3): 345-57   DOI   ScienceOn
11 Hatakeyama J, Sreenath T, Hatakeyama Y, Thyagarajan T, Shum L, Gibson CW. The receptor activator of nuclear factor-kappa B ligand-mediated osteoclastogenic pathway is elevated in amelogenin-null mice. J Biol Chem. 2003;12; 278(37): 35743-8
12 Grzesik WJ, Cheng H, Oh JS, Kuznetsov SA, Mankani MH, Uzawa K, Robey PG, Yamauchi M. Cementun-forming cells are phenotypically distinct from bone-forming cells. J Bone Miner Res. 2000;15:52-59   DOI   ScienceOn
13 Bosshardt DD, Schroeder HE. Cementogenesis reviewed : A comparison between human premolars and rodent molars. Anat Rec. 1996;245:267-292   DOI   ScienceOn
14 Kuznetsov SA, Krebsbach PH, Satomura K, Kerr J, Rimminucci M, Benayahu D, Robey PG. Single colony derived strains of human marrow fibroblasts form bone after transplantation in vitro. J Bone Miner Res. 1997;12:1335- 1347   DOI   ScienceOn
15 Grzesik WJ, Kuznetsov SA, Uzawa K, Mankani M, Gehron Robey P, Yamauchi M. Normal human cementum-derived cells: isolation, clonal expansion and in vitro and in vivo characterization. J Bone Miner Res. 1998;13:1547-1554   DOI
16 Oshiro T, Shiotani A, Shibasaki Y, Sasaki T. Osteoclast induction in periodontal tissue during experimental movement of incisors in osteoprotegerin-deficient mice. Anat Rec. 2002;1;266(4):218-25
17 Freeman E. Periodontium. In:Ten Cate AR(ed.) Oral Histology, 4th Ed., pp.276-312, Mosby-Year Book, Inc., St. Louis, MO, U.S.A., 1994